Identification of numerous hepatitis C virus genotypes in Montreal, Canada.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 229409)

Published in J Clin Microbiol on November 01, 1996

Authors

L Bernier1, B Willems, G Delage, D G Murphy

Author Affiliations

1: Département de Microbiologie et Immunologie, Université de Montréal, Québec, Canada.

Articles citing this

Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol (2007) 2.55

Hepatitis C: a review for primary care physicians. CMAJ (2006) 1.60

Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections. J Clin Microbiol (2000) 1.18

Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain. J Virol (2001) 1.12

Eight novel hepatitis C virus genomes reveal the changing taxonomic structure of genotype 6. J Gen Virol (2012) 0.92

Full-length genome sequences of five hepatitis C virus isolates representing subtypes 3g, 3h, 3i and 3k, and a unique genotype 3 variant. J Gen Virol (2012) 0.87

Epidemiology and treatment of hepatitis C genotypes 5 and 6. Can J Gastroenterol (2013) 0.87

Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e. J Gen Virol (2014) 0.86

Three cases of infection with hepatitis C virus genotype 5 among Brazilian hepatitis patients. J Clin Microbiol (2002) 0.86

Distribution of hepatitis C virus genotypes in Canada: Results from the LCDC Sentinel Health Unit Surveillance System. Can J Infect Dis (1999) 0.85

Molecular and contextual markers of hepatitis C virus and drug abuse. Mol Diagn Ther (2009) 0.80

Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6. World J Clin Cases (2015) 0.79

Nine additional complete genome sequences of HCV genotype 6 from Vietnam including new subtypes 6xb and 6xc. Virology (2014) 0.77

An expanded taxonomy of hepatitis C virus genotype 6: Characterization of 22 new full-length viral genomes. Virology (2015) 0.76

The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study. BMC Infect Dis (2017) 0.75

The Phylogeographic and Spatiotemporal Spread of HCV in Pakistani Population. PLoS One (2016) 0.75

Articles cited by this

Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis (1995) 5.53

A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01

Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10

Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91

Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis (1995) 2.89

Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res (1995) 2.14

Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00

Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol (1996) 1.72

Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem (1995) 1.69

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med (1996) 1.56

Genotyping of Canadian hepatitis C virus isolates by PCR. J Clin Microbiol (1994) 1.23

Biological and clinicopathological features associated with hepatitis C virus type 5 infections. J Hepatol (1996) 1.04

Use of the 5' noncoding region for genotyping hepatitis C virus. J Infect Dis (1994) 0.95

Articles by these authors

The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology (1995) 3.95

Characterization of a new human diploid cell strain, IMR-90. Science (1977) 3.89

Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr (1992) 3.62

The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain (2000) 3.03

Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trial. JAMA (1997) 2.86

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut (2000) 2.55

Structural brain abnormalities associated with deletion at chromosome 22q11: quantitative neuroimaging study of adults with velo-cardio-facial syndrome. Br J Psychiatry (2001) 2.49

Evaluation of the effectiveness of immunization delivery methods. Can J Public Health (1995) 2.36

Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity. J Magn Reson Imaging (1996) 2.01

Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut (1999) 1.91

Evaluation of rubella screening in pregnant women. CMAJ (1998) 1.81

Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J Acquir Immune Defic Syndr (1992) 1.78

Evaluation of donor skin disinfection methods. Transfusion (1997) 1.71

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69

Health spa whirlpools: a source of Pseudomonas folliculitis. Can Med Assoc J (1981) 1.63

Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin. J Virol (1990) 1.61

Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr (1992) 1.56

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology (2000) 1.55

Complications and protocol considerations in carbon monoxide-poisoned patients who require hyperbaric oxygen therapy: report from a ten-year experience. Ann Emerg Med (1989) 1.55

Rotavirus vaccine withdrawal in the United states; the role of postmarketing surveillance. Can J Infect Dis (2000) 1.47

Isometric maximal and submaximal trunk extension at different flexed positions in standing. Triaxial torque output and EMG. Spine (Phila Pa 1976) (1993) 1.45

Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry (1998) 1.44

Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension (1992) 1.42

Lack of age-related differences in temporal lobe volume of very healthy adults. AJNR Am J Neuroradiol (1994) 1.41

Infectious diseases as a subspecialty in Canada: status of the practice in Quebec. Rev Infect Dis (1991) 1.39

Alternative medicine, education and standards of publication and research. J Altern Complement Med (1999) 1.39

Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology (1999) 1.31

Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol (2000) 1.31

Disorder-specific functional abnormalities during sustained attention in youth with Attention Deficit Hyperactivity Disorder (ADHD) and with autism. Mol Psychiatry (2012) 1.27

Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT). Clin Infect Dis (1999) 1.26

Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology (1987) 1.22

The risks and benefits of accepting men who have had sex with men as blood donors. Transfusion (2003) 1.21

Bacterial contamination in platelet concentrates. Vox Sang (2014) 1.18

Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res (1995) 1.16

Risk of HIV infection from blood transfusion in Montreal. CMAJ (1997) 1.16

Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion (2001) 1.16

Acquired (or congenital) immunodeficiency syndrome in infants born of Haitian mothers. N Engl J Med (1983) 1.15

A comparison between emergency diagnostic and treatment unit and inpatient care in the management of acute asthma. Arch Intern Med (1997) 1.15

Hemophilus influenzae type b infections: recurrent disease due to ampicillin-resistant strains. J Pediatr (1977) 1.12

A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology (1994) 1.12

Assessing the diagnostic value of an ECG containing leads V4R, V8, and V9: the 15-lead ECG. Ann Emerg Med (1993) 1.12

Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study. Transl Psychiatry (2013) 1.11

Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses (1995) 1.10

Severe protracted diarrhea due to multiresistant adherent Escherichia coli. Am J Dis Child (1984) 1.10

Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut (2001) 1.09

Smokers can learn to influence their urge to smoke. Addict Behav (2000) 1.09

Antigenic evidence of the presence of the aberrant HIV-1ant70 virus in Cameroon and Gabon. AIDS (1993) 1.09

Prevalence of hepatitis B virus infection in pregnant women in the Montreal area. CMAJ (1986) 1.06

Biological and clinicopathological features associated with hepatitis C virus type 5 infections. J Hepatol (1996) 1.04

Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J Infect Dis (1995) 1.04

Giant-cell pneumonia caused by parainfluenza virus. J Pediatr (1979) 1.04

Immunization delivery methods: practice recommendations. Can J Public Health (1995) 1.03

Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J Neurol Neurosurg Psychiatry (1996) 1.01

Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol (2001) 1.00

Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS (2000) 1.00

Prefrontal and medial temporal correlates of repetitive violence to self and others. Biol Psychiatry (2000) 1.00

Severe disseminated lung disease and bronchiectasis probably due to Mycoplasma pneumoniae. Can Med Assoc J (1977) 0.99

Bacteremia caused by viridans streptococci in 71 children. Can Med Assoc J (1981) 0.99

Adjuvant treatment with polyadenylic-polyuridylic acid (Polya.Polyu) in operable breast cancer. Lancet (1980) 0.98

Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol (1999) 0.98

Canadian Paediatric Surveillance Program evaluation: An excellent report card. Paediatr Child Health (2004) 0.98

Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children. Vaccine (2000) 0.97

Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer. Br J Radiol (2009) 0.96

Visual determinants of reduced performance on the Stroop color-word test in normal aging individuals. J Clin Exp Neuropsychol (2001) 0.95

Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. J Virol Methods (1998) 0.95

Use of the 5' noncoding region for genotyping hepatitis C virus. J Infect Dis (1994) 0.95

Allowing blood donation from men who had sex with men more than 5 years ago: a model to evaluate the impact on transfusion safety in Canada. Vox Sang (2014) 0.95

Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology (1985) 0.95

The urge to smoke depends on the expectation of smoking. Addiction (2002) 0.94

Incidence of positive bacterial cultures after donor call-back. Transfusion (1996) 0.94

Emergency Department Observation Unit versus hospital inpatient care for a chronic asthmatic population: a randomized trial of health status outcome and cost. Med Care (1998) 0.93

Ultrastructural and cytochemical changes in cultured human lung cells. J Ultrastruct Res (1972) 0.93

Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann. Am J Reprod Immunol (1997) 0.92

Adult fragile X syndrome: neuropsychology, brain anatomy, and metabolism. Am J Med Genet (1995) 0.92

Should children with isolated anti-HBs or anti-HBc be immunized against hepatitis B virus? JAMA (1997) 0.92

Primer specific and mispair extension analysis (PSMEA) as a simple approach to fast genotyping. Nucleic Acids Res (1998) 0.91

Screening for HBsAg in pregnant women: a cost analysis of the universal screening policy in the province of Quebec. Can J Public Health (1991) 0.91

Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome. Arch Pathol Lab Med (1984) 0.90

Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx. Blood (1996) 0.90

Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing. AIDS (1998) 0.89

Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol (1997) 0.89

Discriminant analysis of Alzheimer's disease. Arch Neurol (1994) 0.89

Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory. Diagn Microbiol Infect Dis (2000) 0.89

Transjugular intrahepatic portacaval stent shunt as a rescue treatment for life-threatening variceal bleeding in a cirrhotic patient with severe liver failure. Am J Gastroenterol (1992) 0.89

Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease. Biol Psychiatry (1995) 0.89

Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. AIDS Res Hum Retroviruses (1999) 0.88

Effect of methodology on detection of HIV-1/HIV-2 dual infections in Côte d'Ivoire. J Virol Methods (1994) 0.88

Prediction of relapse within eight weeks after an acute asthma exacerbation in adults. J Clin Epidemiol (1998) 0.88

The fecal microflora and bile acids in children with cystic fibrosis. Am J Clin Nutr (1979) 0.87

Interpatient genetic variability of HIV-1 group O. AIDS (1999) 0.86

Defective interfering particles of human parainfluenza virus 3. Virology (1987) 0.86

Occult hepatitis B infection in blood donors. Vox Sang (2008) 0.86

Hepatitis B Infection in Canada: Epidemiology and implications for control. Can Fam Physician (1992) 0.86

"Muskrat fever": two outbreaks of tularemia near Montreal. Can Med Assoc J (1982) 0.86

Tuberculous meningitis in children: a retrospective study of 79 patients, with an analysis of prognostic factors. Can Med Assoc J (1979) 0.85

A fatal case of transfusion-transmitted Staphylococcus epidermidis sepsis. Transfusion (2001) 0.85

Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial. Br Med J (Clin Res Ed) (1984) 0.85

Reduction of functional neuronal connectivity in long-term treated hypertension. Stroke (1994) 0.85